![](https://cms.franciscopartners.com/system/uploads/fae/image/asset/1420/xs_FranciscoPartners-May2022Logos-Avalon__1_.jpg 320w,https://cms.franciscopartners.com/system/uploads/fae/image/asset/1420/sm_FranciscoPartners-May2022Logos-Avalon__1_.jpg 640w,https://cms.franciscopartners.com/system/uploads/fae/image/asset/1420/md_FranciscoPartners-May2022Logos-Avalon__1_.jpg 1024w,https://cms.franciscopartners.com/system/uploads/fae/image/asset/1420/lg_FranciscoPartners-May2022Logos-Avalon__1_.jpg 1400w,https://cms.franciscopartners.com/system/uploads/fae/image/asset/1420/xl_FranciscoPartners-May2022Logos-Avalon__1_.jpg 1800w,https://cms.franciscopartners.com/system/uploads/fae/image/asset/1420/xxl_FranciscoPartners-May2022Logos-Avalon__1_.jpg 2400w)
Status
Current
Detail
- North America
- Healthcare, Tech-Enabled Services
- Partnering with Founders
View Website(opens in new window)
Avalon is a clinically-driven company using evidence-based medicine to develop and deploy appropriate policies and protocols in the high-volume, dynamic and complex lab environment.
The company manages the appropriate use of more than 4,000 current lab tests and researches new tests to determine efficacy and impact on patient care.
Back To Investments